NCT06201221Completed
Single-port Laparoscopy in Children and Adolescents
Advantages of Single-port Laparoscopy in the Treatment of Benign Ovarian Tumors in Children and Adolescents: A Multicenter Retrospective Study
Source: ClinicalTrials.gov · Last updated 11 Jan 2024
Brief summary (registry, in English)
To compare the safety evaluation, efficacy evaluation, long-term aesthetics and psychological satisfaction of single-port and multiport laparoscopy for children and adolescents with BOT in China.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 300 (actual)
- First submitted
- 9 Dec 2023
- Start date
- 1 Jan 2019
- Primary completion date
- 1 Jan 2023
- Lead sponsor
- Fujian Maternity and Child Health Hospital
- Diseases
- Ovarian cancer, Childhood cancers
- NCT number
- NCT06201221
What you commit to
- Study type: Observational
- Participants enrolled: 300
- From 1 Jan 2019 to the primary completion date, 1 Jan 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing open surgery
Other illness
- Patients with malignant pathological diagnosis
Other
- Incomplete medical records or pathological data
Who the study is looking for
- Patients ≤18 years old
- Postoperative pathological diagnosis confirmed benign ovarian tumor
- Multi-hole laparoscopic or single-hole laparoscopic surgery
- Medical records and pathological data were complete and available
Age in the registry: 1 year to 18 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fujian Maternal and Child Health Hospital Coordinator of this site? Confirm its status | Fuzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.